Geneos Wealth Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Geneos Wealth Management’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-200	Closed	-$2.23K	–	2134
2022 Q4	$2.23K	Hold	200	–	–	﹤0.01%	1862
2022 Q3	$1K	Hold	200	–	–	﹤0.01%	1991
2022 Q2	$0	Hold	200	–	–	﹤0.01%	2858
2022 Q1	$2K	Hold	200	–	–	﹤0.01%	2598
2021 Q4	$3K	Hold	200	–	–	﹤0.01%	2556
2021 Q3	$2K	Hold	200	–	–	﹤0.01%	2693
2021 Q2	$3K	Hold	200	–	–	﹤0.01%	2624
2021 Q1	$4K	Hold	200	–	–	﹤0.01%	2764
2020 Q4	$3K	Buy	+200	New	+$4.31K	﹤0.01%	2662

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Geneos Wealth Management's OYST Position: Q1 2023 in Review

Geneos Wealth Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 200 shares — an estimated $2.23K sold.

Geneos Wealth Management first reported a position in OYST in Q4 2020 and held it in 9 quarters. The position peaked at $4K in Q1 2021. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Geneos Wealth Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Geneos Wealth Management sold 200 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $2.23K.
Geneos Wealth Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
Geneos Wealth Management's Oyster Point Pharma, Inc. Common Stock position peaked at $4K in Q1 2021.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Geneos Wealth Management's 13F filing for Q1 2023, filed 25 Apr 2023.